As of March 2024 Haemonetics has a market cap of $4.25 Billion. This makes Haemonetics the world's 2890th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Year | Market cap | Change |
---|---|---|
2024 | $4.25 B | -1.95% |
2023 | $4.33 B | 9.01% |
2022 | $3.98 B | 46.84% |
2021 | $2.71 B | -55.05% |
2020 | $6.02 B | 4.14% |
2019 | $5.78 B | 13.49% |
2018 | $5.10 B | 66.31% |
2017 | $3.06 B | 47.72% |
2016 | $2.07 B | 26.8% |
2015 | $1.63 B | -15% |
2014 | $1.92 B | -11.86% |
2013 | $2.18 B | 3.66% |
2012 | $2.10 B | 37.9% |
2011 | $1.52 B | -2.18% |
2010 | $1.56 B | 12.84% |
2009 | $1.38 B | -3.57% |
2008 | $1.43 B | -11.01% |
2007 | $1.61 B | 35.76% |
2006 | $1.18 B | -8.49% |
2005 | $1.29 B | 38.66% |
2004 | $0.93 B | 57.6% |
2003 | $0.59 B | 14.35% |
2002 | $0.52 B | -42.09% |
2001 | $0.89 B |
On Mar 27th, 2024 the market cap of Haemonetics was reported to be:
Name | Market cap | Market cap differencediff. | Country |
---|---|---|---|
Johnson & Johnson JNJ | $381.35 B | 8,863.99% | ๐บ๐ธ USA |
Medtronic MDT | $115.76 B | 2,621.12% | ๐ฎ๐ช Ireland |
Thermo Fisher Scientific TMO | $221.00 B | 5,094.88% | ๐บ๐ธ USA |
Baxter BAX | $21.72 B | 410.62% | ๐บ๐ธ USA |
Becton Dickinson BDX | $71.34 B | 1,577.04% | ๐บ๐ธ USA |
Stryker Corporation SYK | $136.01 B | 3,097.07% | ๐บ๐ธ USA |
PerkinElmer
PKI | $14.45 B | 239.79% | ๐บ๐ธ USA |
Cerus CERS | $0.34 B | -91.90% | ๐บ๐ธ USA |